These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

85 related items for PubMed ID: 6583206

  • 1. Dependence of HL-60 myeloid cell differentiation on continuous and split retinoic acid exposures: precommitment memory associated with altered nuclear structure.
    Yen A, Reece SL, Albright KL.
    J Cell Physiol; 1984 Mar; 118(3):277-86. PubMed ID: 6583206
    [Abstract] [Full Text] [Related]

  • 2. Control of HL-60 cell differentiation lineage specificity, a late event occurring after precommitment.
    Yen A, Forbes M, DeGala G, Fishbaugh J.
    Cancer Res; 1987 Jan 01; 47(1):129-34. PubMed ID: 3466687
    [Abstract] [Full Text] [Related]

  • 3. c-myc down regulation and precommitment in HL-60 cells due to bromodeoxyuridine.
    Yen A, Forbes ME.
    Cancer Res; 1990 Mar 01; 50(5):1411-20. PubMed ID: 2302706
    [Abstract] [Full Text] [Related]

  • 4. Increased c-myc RNA levels associated with the precommitment state during HL-60 myeloid differentiation.
    Yen A, Guernsey DL.
    Cancer Res; 1986 Aug 01; 46(8):4156-61. PubMed ID: 3460694
    [Abstract] [Full Text] [Related]

  • 5. Evidence for cell cycle phase-specific initiation of a program of HL-60 cell myeloid differentiation mediated by inducer uptake.
    Yen A, Albright KL.
    Cancer Res; 1984 Jun 01; 44(6):2511-5. PubMed ID: 6327017
    [Abstract] [Full Text] [Related]

  • 6. Hydroxyurea indices precommitment during retinoic induced HL-60 terminal myeloid differentiation: possible involvement of gene amplification.
    Yen A, Freeman L, Fishbaugh J.
    Leuk Res; 1987 Jun 01; 11(1):63-71. PubMed ID: 3468316
    [Abstract] [Full Text] [Related]

  • 7. Reversible effects of retinoic acid on glycosaminoglycan synthesis during differentiation of HL-60 leukemia cells.
    Reiss M, Maniglia CA, Sartorelli AC.
    Cancer Res; 1985 May 01; 45(5):2092-7. PubMed ID: 3857115
    [Abstract] [Full Text] [Related]

  • 8. New facts and speculations on human myeloid leukemias.
    Breitman TR, Gallo RC.
    Blood Cells; 1981 May 01; 7(1):79-89. PubMed ID: 6964818
    [Abstract] [Full Text] [Related]

  • 9. Increasing c-FMS (CSF-1 receptor) expression decreases retinoic acid concentration needed to cause cell differentiation and retinoblastoma protein hypophosphorylation.
    Yen A, Sturgill R, Varvayanis S.
    Cancer Res; 1997 May 15; 57(10):2020-8. PubMed ID: 9158000
    [Abstract] [Full Text] [Related]

  • 10. Differentiation of HL-60 cells: cell volume and cell cycle changes.
    Zucker RM, Whittington K, Price BJ.
    Cytometry; 1983 May 15; 3(6):414-8. PubMed ID: 6574016
    [Abstract] [Full Text] [Related]

  • 11. Control of cell differentiation during proliferation. II. Myeloid differentiation and cell cycle arrest of HL-60 promyelocytes preceded by nuclear structural changes.
    Yen A, Reece SL, Albright KL.
    Leuk Res; 1985 May 15; 9(1):51-71. PubMed ID: 3857406
    [Abstract] [Full Text] [Related]

  • 12. FMS (CSF-1 receptor) prolongs cell cycle and promotes retinoic acid-induced hypophosphorylation of retinoblastoma protein, G1 arrest, and cell differentiation.
    Yen A, Sturgill R, Varvayanis S, Chern R.
    Exp Cell Res; 1996 Nov 25; 229(1):111-25. PubMed ID: 8940255
    [Abstract] [Full Text] [Related]

  • 13. Self-renewal and commitment to differentiation of human leukemic promyelocytic cells (HL-60).
    Fibach E, Peled T, Rachmilewitz EA.
    J Cell Physiol; 1982 Oct 25; 113(1):152-8. PubMed ID: 6957411
    [Abstract] [Full Text] [Related]

  • 14. Cell surface membrane protein changes during the differentiation of cultured human promyelocytic leukemia HL-60 cells.
    Felsted RL, Gupta SK, Glover CJ, Fischkoff SA, Gallagher RE.
    Cancer Res; 1983 Jun 25; 43(6):2754-61. PubMed ID: 6573952
    [Abstract] [Full Text] [Related]

  • 15. Control of HL-60 myeloid differentiation. Evidence of uncoupled growth and differentiation control, S-phase specificity, and two-step regulation.
    Yen A.
    Exp Cell Res; 1985 Jan 25; 156(1):198-212. PubMed ID: 3855294
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Inhibition of sterol and phospholipid synthesis in HL-60 promyelocytic leukemia cells by inducers of myeloid differentiation.
    Cooper RA, Ip SH, Cassileth PA, Kuo AL.
    Cancer Res; 1981 May 25; 41(5):1847-52. PubMed ID: 6938303
    [Abstract] [Full Text] [Related]

  • 19. Induction of terminal differentiation and nuclear appendage(s) formation in a human myeloid leukaemia cell line (HL-60).
    Mukherjee AB, Czirbik RJ, Parsa NZ, Testa JR.
    Cytobios; 1985 May 25; 44(176):109-18. PubMed ID: 3867419
    [Abstract] [Full Text] [Related]

  • 20. Combination of a potent 20-epi-vitamin D3 analogue (KH 1060) with 9-cis-retinoic acid irreversibly inhibits clonal growth, decreases bcl-2 expression, and induces apoptosis in HL-60 leukemic cells.
    Elstner E, Linker-Israeli M, Umiel T, Le J, Grillier I, Said J, Shintaku IP, Krajewski S, Reed JC, Binderup L, Koeffler HP.
    Cancer Res; 1996 Aug 01; 56(15):3570-6. PubMed ID: 8758928
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.